NASDAQ:HSIC

Henry Schein Stock Forecast, Price & News

$68.17

-0.94 (-1.36 %)

(As of 01/27/2021 12:00 AM ET)

Add

Compare

Today's Range

$67.03

Now: $68.17▼

$68.98

50-Day Range

$65.72

MA: $69.09▼

$73.88

52-Week Range

$41.85

Now: $68.17▼

$74.89

Volume1.40 million shs

Average Volume786,054 shs

Market Capitalization$9.73 billion

P/E Ratio16.79

Dividend YieldN/A

Beta0.86

Henry Schein, Inc., a solutions company for health care professionals, provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

MarketRank^™

Overall MarketRank^™

1.55 out of 5 stars

Medical Sector

371st out of 1,926 stocks

Medical & Hospital Equipment Industry

2nd out of 7 stocks

1.2 Analyst's Opinion

Consensus Rating
Henry Schein has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 4 buy ratings, 4 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $63.56, Henry Schein has a forecasted downside of 6.8% from its current price of $68.17.
Amount of Analyst Coverage
Henry Schein has only been the subject of 2 research reports in the past 90 days.

1.8 Community Rank

Outperform Votes
Henry Schein has received 330 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Henry Schein has received 598 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Henry Schein has received 64.44% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote “Outperform” if you believe HSIC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HSIC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Henry Schein does not currently pay a dividend.
Dividend Growth
Henry Schein does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Henry Schein insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.05% of the stock of Henry Schein is held by insiders.
Percentage Held by Institutions
94.73% of the stock of Henry Schein is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1 Earnings and Valuation

Earnings Growth
Earnings for Henry Schein are expected to grow by 23.55% in the coming year, from $2.93 to $3.62 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Henry Schein is 16.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.73.
Price to Earnings Ratio vs. Sector
The P/E ratio of Henry Schein is 16.79, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 36.60.
Price to Earnings Growth Ratio
Henry Schein has a PEG Ratio of 3.12. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Henry Schein has a P/B Ratio of 2.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Medical & hospital equipment

Sub-IndustryHealth Care Distributors

SectorMedical

Current SymbolNASDAQ:HSIC

Previous Symbol

CUSIP80640710

CIK1000228

Webwww.henryschein.com

Phone631-843-5500

Employees19,000

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.14

Current Ratio1.49

Quick Ratio0.92

Price-To-Earnings

Trailing P/E Ratio16.79

Forward P/E Ratio23.27

P/E Growth3.12

Sales & Book Value

Annual Sales$9.99 billion

Price / Sales0.97

Cash Flow$4.46 per share

Price / Cash Flow15.30

Book Value$24.74 per share

Price / Book2.76

Profitability

EPS (Most Recent Fiscal Year)$3.51

Net Income$694.73 million

Net Margins6.14%

Return on Equity11.60%

Return on Assets5.70%

Miscellaneous

Outstanding Shares142,776,000

Market Cap$9.73 billion

Next Earnings Date2/18/2021 (Estimated)

OptionableOptionable

$68.17

-0.94 (-1.36 %)

(As of 01/27/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive HSIC News and Ratings via Email

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.

Henry Schein (NASDAQ:HSIC) Frequently Asked Questions

How has Henry Schein's stock price been impacted by COVID-19 (Coronavirus)?

Henry Schein's stock was trading at $57.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HSIC stock has increased by 18.2% and is now trading at $68.17.
View which stocks have been most impacted by COVID-19.

Is Henry Schein a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 1 sell rating, 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Henry Schein stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View analyst ratings for Henry Schein or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Henry Schein?

Wall Street analysts have given Henry Schein a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Henry Schein wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Stanley M. Bergman's approval rating as Henry Schein's CEO?

451 employees have rated Henry Schein CEO Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among Henry Schein's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

When is Henry Schein's next earnings date?

Henry Schein is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for Henry Schein.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) issued its earnings results on Monday, November, 2nd. The company reported $1.03 EPS for the quarter, topping the Zacks' consensus estimate of $0.77 by $0.26. The company earned $2.84 billion during the quarter, compared to analyst estimates of $2.45 billion. Henry Schein had a trailing twelve-month return on equity of 11.60% and a net margin of 6.14%. Henry Schein's quarterly revenue was up 13.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.90 earnings per share.
View Henry Schein's earnings history.

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Shares of Henry Schein split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein declared that its Board of Directors has authorized a stock buyback plan on Thursday, October 31st 2019, which permits the company to buyback $400,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 4.3% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's board believes its stock is undervalued.

What price target have analysts set for HSIC?

9 equities research analysts have issued 1 year price objectives for Henry Schein's stock. Their forecasts range from $50.00 to $79.00. On average, they expect Henry Schein's stock price to reach $63.56 in the next year. This suggests that the stock has a possible downside of 6.8%.
View analysts' price targets for Henry Schein or view Wall Street analyst' top-rated stocks.

Who are some of Henry Schein's key competitors?

Some companies that are related to Henry Schein include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all of HSIC's competitors.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

Who are Henry Schein's key executives?

Henry Schein's management team includes the following people:

Mr. Stanley M. Bergman, Exec. Chairman & CEO (Age 71, Pay $4.77M)
Mr. James P. Breslawski, Exec. Vice Chairman & Pres (Age 67, Pay $1.52M)
Mr. Steven Paladino, Exec. VP, CFO & Exec. Director (Age 64, Pay $1.66M)
Mr. Gerald A. Benjamin, Exec. VP, Chief Admin. Officer & Exec. Director (Age 68, Pay $1.6M)
Mr. Mark E. Mlotek, Exec. VP, Chief Strategic Officer & Exec. Director (Age 65, Pay $1.38M)
Mr. Ronald South, Chief Accounting Officer & VP of Corp. Fin.
Mr. Christopher Pendergast, Sr. VP & CTO (Age 58)
Ms. Carolynne Borders, VP of Investor Relations
Mr. Walter Siegel, Sr. VP & Gen. Counsel (Age 61)
John Lee, VP of Global Compensation & Benefits

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a number of institutional and retail investors. Top institutional investors include Ardevora Asset Management LLP (0.62%), Wedge Capital Management L L P NC (0.30%), Scout Investments Inc. (0.17%), Boston Trust Walden Corp (0.16%), New York State Teachers Retirement System (0.13%) and State of Alaska Department of Revenue (0.08%). Company insiders that own Henry Schein stock include E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Michael S Ettinger, Paul Brons, Philip A Laskawy, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends for Henry Schein.

Which institutional investors are selling Henry Schein stock?

HSIC stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio, Davis R M Inc., Boston Trust Walden Corp, Exchange Traded Concepts LLC, Pacer Advisors Inc., New York State Teachers Retirement System, State of Alaska Department of Revenue, and DNB Asset Management AS. Company insiders that have sold Henry Schein company stock in the last year include Gerald A Benjamin, James P Breslawski, and Walter Siegel.
View insider buying and selling activity for Henry Schein or view top insider-selling stocks.

Which institutional investors are buying Henry Schein stock?

HSIC stock was acquired by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Scout Investments Inc., Kestra Advisory Services LLC, Redpoint Investment Management Pty Ltd, Mission Wealth Management LP, IFM Investors Pty Ltd, Crossmark Global Holdings Inc., and Louisiana State Employees Retirement System.
View insider buying and selling activity for Henry Schein or or view top insider-buying stocks.

How do I buy shares of Henry Schein?

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $68.17.

How big of a company is Henry Schein?

Henry Schein has a market capitalization of $9.73 billion and generates $9.99 billion in revenue each year. The company earns $694.73 million in net income (profit) each year or $3.51 on an earnings per share basis. Henry Schein employs 19,000 workers across the globe.

What is Henry Schein's official website?

The official website for Henry Schein is www.henryschein.com.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]

This page was last updated on 1/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here